Skip to main content

Providers

Female Patient Undergoing Mammogram Screening Procedure.

New FDA Breast Density Law:

Starting in September 2024, a new FDA law requires women be informed about their breast density on their mammogram letters. For women with dense breast, The FDA will mandate that the following statement is required to be on the patients mammo report. Lyra is here to help providers by answering questions and providing ABUS.:

“Your breast tissue is dense. In some people with dense tissue, other imaging tests in addition to mammograms may help find cancers. Talk to your healthcare provider about breast density, risk for breast cancer, and your individual situation”

Woman with holding breast on beige background

Why is this important

As a referring provider, you will be asked about dense breast tissue and the additional tests. Lyra is the only center in Idaho that has the “additional imaging test” by offering ABUS.

At Lyra, we are here to help! Mark the “super order” option and we will take it from there!